Native Collagen Market Summary

The global native collagen market size was valued at USD 160.5 million in 2018 and is projected to reach USD 231.6 million by 2025, expanding at a compound annual growth rate (CAGR) of 5.4% between 2019 and 2025. This market growth is primarily driven by the increasing adoption of native collagen in a range of applications, particularly in cosmetics, healthcare, and pharmaceuticals. Furthermore, rising consumer awareness regarding the medical benefits of native collagen—such as its efficacy in wound healing and in treating joint-related conditions like rheumatoid arthritis and osteoarthritis—is expected to significantly boost product demand over the forecast period.

Native collagen is typically extracted from the bones and cartilages of various animal sources including bovine, poultry, porcine, and marine species. This form of collagen is unprocessed and insoluble, which makes it less likely to be consumed directly or used in typical food and beverage formulations. Despite this, its functional benefits render it highly suitable for specialized applications including bone and joint reconstruction, wound healing, tissue engineering, and the formulation of topical cosmetic products.

Native collagen derived from bovine sources can be extracted from tendons, ligaments, dermis, and blood vessels. Bovine-sourced collagen is especially popular in both medical and cosmetic fields due to its structural compatibility and functional performance. It is commonly used as a thin layer in tissue culture, as well as in medical products like wound dressings, dermal fillers, and biological scaffolds. These applications make bovine collagen a vital component in regenerative medicine and aesthetic formulations.

Key Market Trends & Insights

• In wound care, native collagen dressings are utilized for chronic wound treatment. These dressings are effective because they inhibit the activity of matrix metalloproteinases—enzymes that break down collagen in chronic wounds—thus allowing healing to proceed. Moreover, they help generate new collagen fibers, facilitating angiogenesis (formation of new blood vessels) and overall tissue repair. In cases where bleeding occurs due to shearing of gauze dressings on cutaneous lesions, native collagen sheets serve as a superior alternative by enhancing the wound healing environment and activating the body’s natural repair mechanisms.
• In Europe, the native collagen market is expected to witness substantial growth, primarily fueled by developments in end-use industries like healthcare and cosmetics. Products such as undenatured type II collagen—developed by companies like Lonza—have been clinically tested in the region and shown to enhance joint comfort, flexibility, and mobility, especially in individuals suffering from osteoarthritis. This highlights the rising trend of evidence-backed product adoption in the region.
• North America emerged as a dominant market for native collagen in 2018. The growth can be attributed to the rising demand across nutraceuticals, pharmaceuticals, cosmetics, and other end-use segments. In the region, bovine-derived collagen is particularly favored due to the easy and cost-effective availability of raw materials, making it a go-to source for pharmaceutical applications. The region’s well-established healthcare infrastructure and rising inclination toward natural therapeutic solutions further support this growth.

Order a free sample PDF of the Native Collagen Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2018 Market Size: USD 160.5 million
• 2025 Projected Market Size: USD 231.6 million
• CAGR (2019-2025): 5.4%
• North America: Largest market in 2018

Key Companies & Market Share Insights

Several players in the native collagen market exhibit forward integration across the value chain by not only extracting collagen but also formulating finished products. For example, Symatese is recognized as a leading manufacturer engaged in the production of various collagen forms. Similarly, Vetoquinol S.A. demonstrates a high degree of integration by manufacturing joint health supplements that utilize undenatured type II native collagen. This trend of forward integration helps companies capture greater value and ensure consistent quality control.

The manufacturing of native collagen products involves considerable capital investment, mainly due to stringent regulatory frameworks related to product testing, labeling, and quality assurance. These regulatory hurdles can act as a barrier to entry for new market participants. Consequently, most manufacturers are channeling significant investments into research and development (R&D) to comply with international regulatory standards. Additionally, due to the niche nature of the product, suppliers are increasingly working with multiple supply sources to remain competitive in terms of pricing and to ensure continuous product availability.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global native collagen market is steadily expanding due to growing demand in cosmetics, healthcare, and pharmaceuticals. Rising awareness about its medical applications, especially in wound healing and joint health, is propelling adoption. With Europe and North America leading consumption, driven by clinical advancements and abundant raw materials respectively, the market holds strong regional growth potential. However, high entry barriers and strict regulatory norms necessitate large-scale R&D investments. As more companies integrate across the value chain and pursue multiple sourcing strategies, the market is poised to evolve with enhanced product offerings and wider applications, ensuring steady progress through 2025 and beyond.